|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 60.98 USD | +1.74% |
|
+5.14% | -12.21% |
| 05-01 | UBS Adjusts Price Target on Exponent to $75 From $85, Maintains Neutral Rating | MT |
| 04-30 | Exponent, Inc., Q1 2026 Earnings Call, Apr 30, 2026 |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 81.67 | +36.25% | 3 | ||||||
| 208.69 | +19.78% | 16 | ||||||
| 127.73 | +12.97% | 11 | ||||||
| 158.27 | +26.99% | 15 | ||||||
| 31.47 | +17.86% | 17 | ||||||
| 58.44 | +0.67% | 13 | ||||||
| 24.07 | +4.51% | 14 | ||||||
| 292.17 | +7.57% | 12 | ||||||
| 74.31 | +18.33% | 8 | ||||||
| - | 271.67 | +1.92% | 3 | |||||
| 42.45 | +50.23% | 11 | ||||||
| 41.75 | +55.84% | 8 | ||||||
| 153 | +54.55% | 2 | ||||||
| 78.15 | +55.75% | 13 | ||||||
| - | 50.27 | +14.01% | 3 | |||||
| 1,364 | +29.6% | 5 | ||||||
| 3.104 | +37.47% | 12 | ||||||
| - | 105 | +95.06% | 2 | |||||
| 52.43 | +17.71% | 7 | ||||||
| Average | 169.4 | +29.32% | 9 | ||||||
| Weighted average by Cap. | 163.07 | +21.31% | 13 |
- Stock Market
- Stocks
- EXPO Stock
- Sector Exponent, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
